BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26859792)

  • 1. Ototoxicity and cancer therapy.
    Landier W
    Cancer; 2016 Jun; 122(11):1647-58. PubMed ID: 26859792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in ototoxicity monitoring in the pediatric oncology population.
    Bass JK; Bhagat SP
    J Am Acad Audiol; 2014 Sep; 25(8):760-74; quiz 782-3. PubMed ID: 25380122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced ototoxicity. Pathogenesis and prevention.
    Huang MY; Schacht J
    Med Toxicol Adverse Drug Exp; 1989; 4(6):452-67. PubMed ID: 2689838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ototoxic complications of chemotherapy].
    Ligeziński A
    Pol Merkur Lekarski; 2002 Feb; 12(68):147-51. PubMed ID: 11995254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological intervention in the field of ototoxicity.
    Laurell G
    HNO; 2019 Jun; 67(6):434-439. PubMed ID: 30993373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hearing and Other Neurologic Problems.
    Landier W; Cohn RJ; van den Heuvel-Eibrink MM
    Pediatr Clin North Am; 2020 Dec; 67(6):1219-1235. PubMed ID: 33131543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hearing loss related to ototoxicity in children with cancer.
    Landier W
    J Pediatr Oncol Nurs; 1998 Oct; 15(4):195-206. PubMed ID: 9810786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of genetic and non genetic risk factors for cisplatin ototoxicity in pediatric patients.
    Olgun Y; Aktaş S; Altun Z; Kırkım G; Kızmazoğlu DÇ; Erçetin AP; Demir B; İnce D; Mutafoğlu K; Demirağ B; Ellidokuz H; Olgun N; Güneri EA
    Int J Pediatr Otorhinolaryngol; 2016 Nov; 90():64-69. PubMed ID: 27729156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced tinnitus and other hearing disorders.
    Seligmann H; Podoshin L; Ben-David J; Fradis M; Goldsher M
    Drug Saf; 1996 Mar; 14(3):198-212. PubMed ID: 8934581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo models of drug ototoxicity: studying the mechanisms of a clinical problem.
    Yorgason JG; Luxford W; Kalinec F
    Expert Opin Drug Metab Toxicol; 2011 Dec; 7(12):1521-34. PubMed ID: 21999330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hearing loss and vestibular dysfunction among children with cancer after receiving aminoglycosides.
    Chen KS; Bach A; Shoup A; Winick NJ
    Pediatr Blood Cancer; 2013 Nov; 60(11):1772-7. PubMed ID: 23788258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOD2 genetic variant associated with treatment-related ototoxicity in cisplatin-treated pediatric medulloblastoma.
    Brown AL; Lupo PJ; Okcu MF; Lau CC; Rednam S; Scheurer ME
    Cancer Med; 2015 Nov; 4(11):1679-86. PubMed ID: 26400460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding platinum-induced ototoxicity.
    Langer T; am Zehnhoff-Dinnesen A; Radtke S; Meitert J; Zolk O
    Trends Pharmacol Sci; 2013 Aug; 34(8):458-69. PubMed ID: 23769626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transtympanic Ringer's lactate application in the prevention of cisplatinum-induced ototoxicity in a chinchilla animal model.
    Munguia R; Sahmkow SI; Funnell WR; Daniel SJ
    Otolaryngol Head Neck Surg; 2010 Jul; 143(1):134-40. PubMed ID: 20620632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma.
    Jehanne M; Lumbroso-Le Rouic L; Savignoni A; Aerts I; Mercier G; Bours D; Desjardins L; Doz F
    Pediatr Blood Cancer; 2009 May; 52(5):637-43. PubMed ID: 19148943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relevance of ototoxicity induced by radiotherapy.
    Huang Y; Zhou H; An F; Zhao A; Wu J; Wang M; Luo J
    Radiat Oncol; 2023 Jun; 18(1):95. PubMed ID: 37270526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy.
    Moeller BJ; Chintagumpala M; Philip JJ; Grosshans DR; McAleer MF; Woo SY; Gidley PW; Vats TS; Mahajan A
    Radiat Oncol; 2011 Jun; 6():58. PubMed ID: 21635776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of chemotherapy-induced inner ear damage on quality of life in cancer survivors: a qualitative study.
    Pearson SE; Caimino C; Shabbir M; Baguley DM
    J Cancer Surviv; 2022 Oct; 16(5):976-987. PubMed ID: 34398361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of ototoxic effect of cisplatin with otoacoustic emission in testicular cancer patients].
    Biró K
    Magy Onkol; 2009 Sep; 53(3):279-83. PubMed ID: 19793694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.